Status:
RECRUITING
IRIS-Coroflex NEO Cohort
Lead Sponsor:
Seung-Jung Park
Collaborating Sponsors:
The CardioVascular Research Foundation (CVRF)
Conditions:
Coronary Artery Stenosis
Coronary Artery Disease
Eligibility:
All Genders
19+ years
Brief Summary
The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.
Eligibility Criteria
Inclusion
- Patients ≥ 19 years old
- Patients receiving Coroflex ISAR NEO stents.
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion
- Patients with a mixture of other DESs
- Terminal illness with life expectancy \<1 year.
- Patients with cardiogenic shock
Key Trial Info
Start Date :
January 9 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06177743
Start Date
January 9 2025
End Date
December 31 2030
Last Update
June 11 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, Songpa-gu, South Korea, 138-736
2
Bucheon Sejong Hospital
Bucheon-si, South Korea
3
The Catholic Univ. of Korea BUCHEON ST.Mary's hospital
Bucheon-si, South Korea
4
Veterans Hospital
Daegu, South Korea